What are the characteristics and management of Melanonychia (nail plate pigmentation)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Melanonychia: Characteristics and Management

Melanonychia is characterized by brown to black pigmentation of the nail plate caused by melanin deposition, which can be due to benign causes in most cases but may also indicate subungual melanoma requiring prompt evaluation and management.

Clinical Presentation and Etiology

  • Melanonychia typically presents as longitudinal melanonychia (LM), which appears as tan, brown, or black longitudinal streaks within the nail plate running from the proximal nail fold to the distal edge 1
  • Two main mechanisms cause melanonychia: melanocytic activation (increased activity of normal melanocytes) and melanocytic hyperplasia (increased number of melanocytes) 2
  • Common benign causes include:
    • Ethnic/racial melanonychia in dark-skinned individuals (most common cause) 1
    • Pregnancy, chronic trauma, infections 1
    • Medications, particularly taxanes and other chemotherapeutic agents 3
    • Systemic conditions including endocrine disorders, hemochromatosis, and Peutz-Jeghers syndrome 1

Differential Diagnosis

  • It's essential to differentiate melanonychia from other nail conditions such as:
    • Subungual hematoma (blood collection under the nail) 4
    • Onychomycosis (fungal nail infection) 3
    • Onycholysis (separation of nail plate from nail bed), which may appear black, white, or brown-red 3

Evaluation and Assessment

  • Suspicious features that may indicate subungual melanoma include:
    • Abrupt onset after middle age 1
    • Personal or family history of melanoma 1
    • Rapid growth or darkening of a melanonychia band 1
    • Pigment variegation or blurry lateral borders 1
    • Bandwidth >3 mm or proximal widening 1
    • Single digit involvement (rather than multiple) 1
    • Hutchinson sign (periungual spread of pigmentation onto adjacent cuticle and/or nail folds) 1
    • Associated nail plate dystrophy 1

Management Approach

  • For benign-appearing melanonychia, especially in children, a wait-and-see approach with regular monitoring is appropriate 1
  • Dermoscopy can be helpful in evaluating melanonychia, though its definitive benefit in screening lesions remains to be fully established 5
  • Biopsy is indicated when:
    • Features suspicious for melanoma are present 6
    • There is uncertainty about the diagnosis 7
    • The lesion is changing rapidly 1

Biopsy Techniques

  • Nail matrix biopsy is the gold standard for diagnosis of suspicious melanonychia 6
  • The appropriate biopsy technique depends on:
    • Location of the pigmented band 6
    • Width of the band 6
    • Degree of clinical suspicion for melanoma 6

Prevention and Management of Medication-Induced Melanonychia

  • For medication-induced melanonychia (particularly with taxanes):
    • Daily application of topical emollients on periungual folds, matrix, and nail plate 3
    • Use of protective nail lacquers to limit water loss from the nail plate 3
    • Avoiding nail trauma, excessive water exposure, and harsh chemicals 8
    • For taxane therapy, frozen gloves (10-30°C for 90 minutes) have shown significant reduction in nail changes 3

Follow-up

  • Prolonged follow-up is mandatory for early detection of possible malignant changes in persistent melanonychia 1
  • Patients with nail apparatus melanoma are often initially misdiagnosed, leading to diagnostic delays averaging 2 years, which contributes to poor prognosis 2
  • Regular monitoring with clinical photography and dermoscopy can help detect changes over time 7

Special Considerations

  • Melanonychia in children is almost always benign, but should still be monitored 1
  • In patients receiving chemotherapy, particularly taxanes, melanonychia may be part of a constellation of nail changes including onycholysis 3
  • Subungual melanoma carries a higher mortality rate compared to other cutaneous melanomas, often due to delayed diagnosis 6

References

Research

Melanonychia.

Dermatology research and practice, 2012

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Subungual Hematoma Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Dealing with melanonychia.

Seminars in cutaneous medicine and surgery, 2009

Research

Longitudinal melanonychia: detection and management of nail melanoma.

Hand surgery : an international journal devoted to hand and upper limb surgery and related research : journal of the Asia-Pacific Federation of Societies for Surgery of the Hand, 2013

Guideline

Nail Disorders: Trachyonychia and Onychorrhexis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.